Granulocyte-Colony Stimulating Factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults (Q24246628)

Cochrane Database of Systematic Reviews

Europe PubMed Central

title

Granulocyte-Colony Stimulating Factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults (English)

0 references

0 references

AC Cheng

1

0 references

DP Stephens

series ordinal

2

0 references

BJ Currie

series ordinal

3

0 references

publication date

19 July 2004

0 references

published in

0 references

cites work

A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia. CAP Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004400.PUB2

Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004400.PUB2

Filgrastim in patients with pneumonia and severe sepsis or septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004400.PUB2

Effects of granulocyte colony-stimulating factor (G-CSF) treatment on granulocyte function and receptor expression in patients with ventilator-dependent pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004400.PUB2

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004400.PUB2

Granulocyte colony-stimulating factor or neutrophil-induced pulmonary toxicity: myth or reality? Systematic review of clinical case reports and experimental data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004400.PUB2

Therapeutic use of granulocyte and granulocyte-macrophage colony-stimulating factors in febrile neutropenic cancer patients. A systematic review of the literature with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004400.PUB2

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004400.PUB2

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004400.PUB2

Severe community-acquired pneumonia. Assessment of severity criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004400.PUB2

Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004400.PUB2

Evaluation of clinical judgment in the identification and treatment of nosocomial pneumonia in ventilated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004400.PUB2

A prediction rule to identify low-risk patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004400.PUB2

Protective effect of recombinant human granulocyte colony-stimulating factor against pneumococcal infections in splenectomized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004400.PUB2

7 January 2021

CDC definitions for nosocomial infections, 1988

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004400.PUB2

7 January 2021

An audit of the use of granulocyte colony-stimulating factor in septic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004400.PUB2

7 January 2021

Community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004400.PUB2

7 January 2021

A randomized controlled trial of filgrastim for the treatment of hospitalized patients with multilobar pneumonia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004400.PUB2

7 January 2021

Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004400.PUB2

7 January 2021

Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004400.PUB2

7 January 2021